使用斑马鱼振动惊吓反应筛查系统评估化学品的毒性
2024年1月12日
2.5K 次观看
我们描述了筛选系统的工作流程和数据分析，用于基于斑马鱼胚胎振动惊吓反应评估化合物毒性。该系统记录斑马鱼胚胎在暴露于振动刺激时的运动，并允许对一般毒性/致死性和神经肌肉毒性进行综合评估。
在筛选化学品的毒性时，目前的实验挑战是确定体内的毒性作用，同时考虑到整个生物体的复杂性，并以快速、高通量的方式做到这一点。通过使用行为读数来监测斑马鱼胚胎对振动刺激的逃逸反应，我们的系统使我们能够识别干扰神经或肌肉功能的化合物。由于死胚胎不会移动，我们还捕获了通过非特异性毒性引起致死的化合物。
我们提供的系统可以以适中的价格构建，并且是可定制的。它也易于维护，所有部件都可以更换。我们目前正在使用 PrecisionTox 联盟内的惊吓测定系统来确定用于 OMICS 数据采集的化合物剂量。
这些数据是在五种模式生物和人类细胞系中生成的。它们将用于推导用于人类毒性预测的毒性途径和生物标志物。
概览
本研究使用斑马鱼胚胎振动惊跳反应来评估化学化合物毒性。通过监测胚胎对振动刺激的反应，该系统评估了各种化合物的神经肌肉毒性和一般致死性。
主要研究组成部分
研究领域
- 毒性筛选
- 神经毒理学
- 发育生物学
背景
- 由于生物体的复杂性，体内毒性筛选具有挑战性。
- 斑马鱼胚胎为评估化学物质的影响提供了适当的模型。
- 该工作是为人类毒性预测推导毒性途径的努力的一部分。
所用方法
- 行为测定法，以测量斑马鱼胚胎的惊跳反应。
- 胚胎被孵化并暴露于各种浓度的待测化学品。
- 通过运动反应的可视化和基准浓度计算进行数据分析。
主要结果
- 确定了降低运动能力并导致致死的化合物。
- 量化了特定毒性的基准浓度。
- 证明该系统是可定制和具有成本效益的。
结论
- 该系统通过简单和可重复的测定法有效地识别毒性化合物。
- 有助于理解与斑马鱼和人类相关的化学毒性途径。
常见问题
为什么在毒性测试中使用斑马鱼胚胎？
使用斑马鱼胚胎是因为它们的透明身体和快速发育，允许轻松观察化学物质暴露的影响。
测定中的振动惊跳反应如何工作？
该测定法测量胚胎对快速振动的逃逸反应，表明化学物质如何影响神经肌肉功能。
使用这个系统可以测试什么样的化合物？
该系统可以测试各种化学化合物，帮助识别一般毒性和特定的神经毒性效应。
测定法可以根据不同的研究需求进行调整吗？
是的，筛选系统是可定制的，可以适应各种实验设计。
这项研究有什么意义？
研究结果有助于化学物质的安全评估，并帮助识别潜在的人类毒性途径。
从这种方法获得的结果有多准确？
该方法提供了关于胚胎行为反应的可靠数据，这与毒性水平相关。
是否有必要为测定法配备专门的设备？
虽然需要一些专门的设备，但整体设置可以以适中的成本实现。
Executive Industry Relevance
High-throughput in vivo toxicity screening remains a critical bottleneck in early drug discovery and chemical safety assessment. The zebrafish vibration startle response system enables rapid, quantitative evaluation of neuromuscular and general toxicity, supporting predictive confidence at the target validation and lead triage stages. Its modular, scalable design aligns with enterprise needs for reproducibility, cost efficiency, and translational relevance across diverse compound portfolios.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Enables functional interrogation of neuromuscular toxicity and lethality in a whole-organism context.
- Supports biological de-risking by distinguishing specific neuroactive effects from general cytotoxicity.
- Facilitates predictive confidence in target engagement and off-target safety liabilities.
Screening & Assay Development
- Provides a standardized behavioral assay for quantitative, reproducible toxicity readouts.
- Delivers scalable throughput via modular assembly and automated video capture.
- Enables robust compound evaluation for both acute and sublethal toxic effects.
Translational & Preclinical Research
- Aligns with multi-species OMICS workflows for toxicity pathway elucidation.
- Supports biomarker discovery and cross-species translational continuity.
- Informs risk-adjusted advancement decisions by integrating organism-level toxicity data.
Pipeline & Workflow Integration
This zebrafish-based assay bridges early discovery and preclinical safety workflows, providing actionable toxicity data prior to mammalian studies.
- Discovery Biology: Quantifies behavioral phenotypes to clarify mechanistic toxicity and pathway involvement.
- Screening: Offers reproducible, high-content outputs for compound triage and prioritization.
- Analytics: Generates benchmark concentration values and immotility rates for comparative analysis.
- Translational Research: Integrates with OMICS and multi-model organism pipelines for human toxicity prediction.
- Enterprise Reuse: Modular system design supports adaptation across diverse screening and safety platforms.
Operational & Enterprise Impact
- Scientific Value: Increases predictive confidence and reduces mechanistic ambiguity in toxicity assessment.
- Operational Value: Delivers standardized, scalable, and cost-effective screening capability.
- Strategic Value: Improves go/no-go decisions and reduces late-stage attrition due to unforeseen toxicity.
- Portfolio Impact: Enables risk-adjusted prioritization and efficient resource allocation across discovery programs.
Implementation Considerations
- Requires expertise in zebrafish husbandry and behavioral phenotyping.
- Needs basic imaging infrastructure and data analysis tools (e.g., VirtualDub, KNIME with R scripts).
- Demands cross-team standardization for assay setup and scoring criteria.
- Adaptable to various compound classes and exposure paradigms.
- Assay robustness may be affected by embryo quality and developmental variability.
Biopharma FAQs
Why does null hypothesis testing matter for startle response quantification?
Null hypothesis testing enables objective determination of whether observed changes in zebrafish embryo motility are statistically significant compared to controls, supporting rigorous target validation and minimizing false positives in toxicity screening.
How does independent variable isolation improve chemical exposure assessment?
Isolating chemical concentration as the independent variable ensures that observed effects on startle response are attributable to the test compound, enhancing discovery-stage confidence and supporting mechanistic de-risking.
What do quantitative immotility measurements enable in toxicity workflows?
Quantitative immotility rates provide reproducible, dose-dependent endpoints for benchmarking compound toxicity, enabling direct comparison across compounds and supporting data-driven triage decisions.
Why are replication requirements critical for cross-functional screening teams?
Replication across multiple embryo clutches and experimental runs ensures assay robustness and reproducibility, facilitating reliable data sharing and collaboration between discovery, safety, and translational teams.
What statistical analysis capabilities are needed before benchmark concentration reporting?
Robust statistical workflows, such as KNIME pipelines with embedded R scripts, are required to calculate benchmark concentrations and validate immotility thresholds, ensuring data integrity before downstream implementation.
